Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial

Elias Jabbour; Nicholas J. Short; Nitin Jain; Xuelin Huang; Guillermo Montalban‐Bravo; Pinaki P. Banerjee; Katayoun Rezvani; Xianli Jiang; Kun Hee Kim; Rashmi Kanagal‐Shamanna; Joseph D. Khoury; Keyur P. Patel; Tapan M. Kadia; Naval Daver; Kelly S. Chien; Yesid Alvarado; Guillermo Garcia‐Manero; Ghayas C. Issa; Fadi Haddad; Monica Kwari; Jennifer Thankachan; Ricardo Delumpa; Walid Macaron; Rebecca Garris; Marina Konopleva; Farhad Ravandi; Hagop M. Kantarjian

doi:10.1016/s2352-3026(22)00319-2

Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial

Elias Jabbour(The University of Texas MD Anderson Cancer Center), Nicholas J. Short(The University of Texas MD Anderson Cancer Center), Nitin Jain(The University of Texas MD Anderson Cancer Center), Xuelin Huang(The University of Texas MD Anderson Cancer Center), Guillermo Montalban‐Bravo(The University of Texas MD Anderson Cancer Center), Pinaki P. Banerjee(The University of Texas MD Anderson Cancer Center), Katayoun Rezvani(The University of Texas MD Anderson Cancer Center), Xianli Jiang(The University of Texas MD Anderson Cancer Center), Kun Hee Kim(The University of Texas MD Anderson Cancer Center), Rashmi Kanagal‐Shamanna(The University of Texas MD Anderson Cancer Center), Joseph D. Khoury(The University of Texas MD Anderson Cancer Center), Keyur P. Patel(The University of Texas MD Anderson Cancer Center), Tapan M. Kadia(The University of Texas MD Anderson Cancer Center), Naval Daver(The University of Texas MD Anderson Cancer Center), Kelly S. Chien(The University of Texas MD Anderson Cancer Center), Yesid Alvarado(The University of Texas MD Anderson Cancer Center), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center), Ghayas C. Issa(The University of Texas MD Anderson Cancer Center), Fadi Haddad(The University of Texas MD Anderson Cancer Center), Monica Kwari(The University of Texas MD Anderson Cancer Center), Jennifer Thankachan(The University of Texas MD Anderson Cancer Center), Ricardo Delumpa(The University of Texas MD Anderson Cancer Center), Walid Macaron(The University of Texas MD Anderson Cancer Center), Rebecca Garris(The University of Texas MD Anderson Cancer Center), Marina Konopleva(The University of Texas MD Anderson Cancer Center), Farhad Ravandi(The University of Texas MD Anderson Cancer Center), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center)

The Lancet Haematology

November 16, 2022

10.1016/s2352-3026(22)00319-2

Cited by 234

Abstract

Related Papers

No related papers found

Powered by citation graph analysis